196 related articles for article (PubMed ID: 18930124)
21. GATA transcription factors in hematologic disease.
Cantor AB
Int J Hematol; 2005 Jun; 81(5):378-84. PubMed ID: 16158817
[TBL] [Abstract][Full Text] [Related]
22. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
23. [The role of GATA1 mutation in acute megakaryocytic leukemia].
Ito E
Rinsho Ketsueki; 2006 Nov; 47(11):1415-22. PubMed ID: 17176883
[No Abstract] [Full Text] [Related]
24. GATA factor mutations in hematologic disease.
Crispino JD; Horwitz MS
Blood; 2017 Apr; 129(15):2103-2110. PubMed ID: 28179280
[TBL] [Abstract][Full Text] [Related]
25. Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
Vyas P; Roberts I
Early Hum Dev; 2006 Dec; 82(12):767-73. PubMed ID: 17064858
[TBL] [Abstract][Full Text] [Related]
26. Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
Heald B; Hilden JM; Zbuk K; Norton A; Vyas P; Theil KS; Eng C
Nat Clin Pract Oncol; 2007 Jul; 4(7):433-8. PubMed ID: 17597708
[TBL] [Abstract][Full Text] [Related]
27. Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21.
Hoeller S; Bihl MP; Tzankov A; Chaffard R; Hirschmann P; Miny P; Kühne T; Bruder E
Hum Pathol; 2014 May; 45(5):1003-9. PubMed ID: 24746204
[TBL] [Abstract][Full Text] [Related]
28. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
[TBL] [Abstract][Full Text] [Related]
29. Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis.
Di Pierro E; Russo R; Karakas Z; Brancaleoni V; Gambale A; Kurt I; Winter SS; Granata F; Czuchlewski DR; Langella C; Iolascon A; Cappellini MD
Eur J Haematol; 2015 Jun; 94(6):491-7. PubMed ID: 25251786
[TBL] [Abstract][Full Text] [Related]
30. GATA 1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome--a new tool with significant potential applications.
Hitzler J; Zipursky A
Leuk Res; 2005 Nov; 29(11):1239-40. PubMed ID: 15925405
[No Abstract] [Full Text] [Related]
31. Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome.
Sato T; Toki T; Kanezaki R; Xu G; Terui K; Kanegane H; Miura M; Adachi S; Migita M; Morinaga S; Nakano T; Endo M; Kojima S; Kiyoi H; Mano H; Ito E
Br J Haematol; 2008 May; 141(5):681-8. PubMed ID: 18397343
[TBL] [Abstract][Full Text] [Related]
32. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
[TBL] [Abstract][Full Text] [Related]
33. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
34. Successful hematopoietic stem cell transplantation in a child with congenital erythropoietic porphyria due to a mutation in GATA-1.
Karakurt N; Tavil B; Azik F; Tunc B; Karakas Z; Uckan-Cetinkaya D
Pediatr Transplant; 2015 Nov; 19(7):803-5. PubMed ID: 26392207
[No Abstract] [Full Text] [Related]
35. An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis.
Hollanda LM; Lima CS; Cunha AF; Albuquerque DM; Vassallo J; Ozelo MC; Joazeiro PP; Saad ST; Costa FF
Nat Genet; 2006 Jul; 38(7):807-12. PubMed ID: 16783379
[TBL] [Abstract][Full Text] [Related]
36. Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.
Xu G; Kanezaki R; Toki T; Watanabe S; Takahashi Y; Terui K; Kitabayashi I; Ito E
Leukemia; 2006 Jun; 20(6):1002-8. PubMed ID: 16628190
[TBL] [Abstract][Full Text] [Related]
37. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia I ultrastructure.
White JG; Nichols WL; Steensma DP
Platelets; 2007 Jun; 18(4):273-83. PubMed ID: 17538848
[TBL] [Abstract][Full Text] [Related]
38. GATA Transcription Factors: Basic Principles and Related Human Disorders.
Fujiwara T
Tohoku J Exp Med; 2017 Jun; 242(2):83-91. PubMed ID: 28566565
[TBL] [Abstract][Full Text] [Related]
39. GATA1-related leukaemias.
Shimizu R; Engel JD; Yamamoto M
Nat Rev Cancer; 2008 Apr; 8(4):279-87. PubMed ID: 18354416
[TBL] [Abstract][Full Text] [Related]
40. A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia.
Majewski IJ; Metcalf D; Mielke LA; Krebs DL; Ellis S; Carpinelli MR; Mifsud S; Di Rago L; Corbin J; Nicola NA; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14146-51. PubMed ID: 16966598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
